CCN1 sensitizes esophageal cancer cells to TRAIL-mediated apoptosis.

@article{Dang2017CCN1SE,
  title={CCN1 sensitizes esophageal cancer cells to TRAIL-mediated apoptosis.},
  author={Tong Dang and Cristina Modak and Xiemei Meng and Jinbao Wu and R. Byron Narvaez and Jianyuan Chai},
  journal={Experimental cell research},
  year={2017},
  volume={361 1},
  pages={163-169}
}
TRAIL is one of the best anti-cancer molecules in our body. It kills a variety of cancer cells that are resistant to conventional chemotherapy, without causing much negative impact on normal cells, because its death receptors are almost exclusively found on cancer cells. However, some cancer cells are not sensitive to TRAIL treatment, even though they express its death receptors. A second molecule is needed to help TRAIL to complete its mission. Finding such molecules now becomes a top priority… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 55 references

CaMos research Group

L. A. Fraser, W. D. Leslie, L. E. Targownik, A. Papaioannou, J. D. Adachi
The effect of proton pump inhibitors on fracture risk: report from the Canadian multicenter osteoporosis study, Osteoporos. Int. 24 • 2013
View 1 Excerpt

Osteoprotegerin (OPG) activates integrin

D. Lane, I. Matte, +3 authors A. Piché
focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis, J. Ovarian Res. 6 • 2013

Esophageal malignancy: a growing concern.

World journal of gastroenterology • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…